QUOTE AND NEWS
StreetInsider.com  Apr 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Transcept+%28TSPT%29+Announces+Common+Offering/7372694.html for the full story.
StreetInsider.com  Apr 10  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Transcept+Pharma+%28TSPT%29+Names+Soloway+as+Exec+VP%2C+COO/7335823.html for the full story.
StreetInsider.com  Apr 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+%28TSPT%29+Reports+New+Dosages+of+Intermezzo+Available+for+Prescription/7326696.html for the full story.
Benzinga  Mar 26  Comment 
According to a research report published earlier today, MLV & Co. has increased Transcept Pharmaceuticals' (NASDAQ: TSPT) PT from $21 to $24. MLV & Co. said in the report, “As Transcept prepares to collect royalty revenue for the first time...
StreetInsider.com  Dec 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+Pharmaceuticals+%28TSPT%29+Earns+%2410+Million+in+Milestone+Payments+from+Purdue/7037441.html for the full story.
StreetInsider.com  Dec 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+%28TSPT%29+Announces+Purdue+Exercised+Option+to+Commercialize+Intermezzo+in+the+US%3B+Shares+Rallying/6986890.html for the full story.
StreetInsider.com  Nov 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+%28TSPT%29+Intermezzo+Approved+by+FDA/6973898.html for the full story.
StreetInsider.com  Nov 1  Comment 
UPGRADES Credit Suisse upgrades Citi (NYSE: C) from Neutral to Outperform, with a price target of $48. BofA/Merrill Lynch lifts AMERIGROUP (NYSE: AGP) from Underperform to Neutral. McNicoll Lewis & Vlak boosts Transcept Pharmaceuticals (Nasdaq:...
Benzinga  Sep 28  Comment 
McNicoll Lewis Vlak has released a research report on Transcept Pharmaceuticals (NASDAQ: TSPT) and has raised the price target from $5.50 to $8. In the report, McNicoll Lewis Vlak writes, "We remain cautious, but have little double that TSPT...
StreetInsider.com  Sep 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Transcept+Pharma+%28TSPT%29+Resubmits+Intermezzo+NDA+to+FDA/6815396.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki